The Music4Diabetes consortium has unveiled an ambitious initiative aimed at revolutionizing Type 1 Diabetes treatment. The latest project involves the development of an implantable multi-metabolite sensor, seamlessly integrated with a continuous insulin delivery pump. This innovative approach promises to significantly enhance the management of Type 1 Diabetes.

 Proudly standing as one of the seven key consortium members, Indigo is excited to announce the commencement of this transformative venture. Thanks to a prestigious €3.8m grant from the European Innovation Council pathway programme, the project is poised for success from the outset.

 For more information on the MuSiC4Diabetes project, visit the newly launched website:



Pin It on Pinterest